New York State Common Retirement Fund
ALGS icon

New York State Common Retirement Fund’s Aligos Therapeutics ALGS Stock Holding History

New York State Common Retirement Fund’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7
Closed – – 3263
2022
Q2 		$0 Sell
7
-535
-99% -$18.2K ﹤0.01% 3467
2022
Q1 		$29K Hold
542
– – ﹤0.01% 3254
2021
Q4 		$161K Sell
542
-110
-17% -$40.1K ﹤0.01% 2949
2021
Q3 		$253K Buy
652
+4
+0.6% +$1.58K ﹤0.01% 2815
2021
Q2 		$330K Buy
648
+260
+67% +$166K ﹤0.01% 2804
2021
Q1 		$221K Buy
388
+160
+70% +$106K ﹤0.01% 2796
2020
Q4 		$158K Buy
+228
New +$111K ﹤0.01% 2834

Other funds holding ALGS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund's ALGS Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Aligos Therapeutics (ALGS) in Q3 2022, closing a stake of 7 shares.

New York State Common Retirement Fund first reported a position in ALGS in Q4 2020 and held it in 7 quarters. The position peaked at $330K in Q2 2021. 52 funds tracked by Wall St. Rank hold ALGS as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Aligos Therapeutics position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 7 Aligos Therapeutics shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in Aligos Therapeutics in Q4 2020 and held it in 7 quarters.
  • New York State Common Retirement Fund's Aligos Therapeutics position peaked at $330K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.